Bruce Waldholtz
Gastroenterology · Chesapeake, VANPI 1871592840
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 259 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 31.5% of the total. Reporting peaked in 2019 at $1,495 and has fallen 82.4% since, to $263 in 2023.
Across 259 payments — averaging $18.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$704
- Takeda Pharmaceuticals U.S.A., Inc.$438
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$376
- Daiichi Sankyo Inc.$303
- Nestle Healthcare Nutrition Inc.$209
- plus $1K from 19 others
What the payments were for
- Food & beverage$4,66898%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 85 | $1,502 |
| Johnson & Johnson | 39 | $704 |
| Takeda Pharmaceuticals U.S.A., Inc. | 33 | $438 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $376 |
| Daiichi Sankyo Inc. | 15 | $303 |
| Nestle Healthcare Nutrition Inc. | 12 | $209 |
| Bristol Myers Squibb | 12 | $183 |
| Boston Scientific | 3 | $148 |
| Intra-sana Laboratories | 1 | $140 |
| Ironwood Pharmaceuticals, Inc | 8 | $129 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| Gilead | 1 | $111 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Merck | 4 | $60 |
| Braintree Laboratories, Inc. | 2 | $35 |
| Shire North American Group Inc | 2 | $33 |
| Alfasigma USA, Inc. | 2 | $32 |
| Intercept Pharmaceuticals, Inc. | 2 | $29 |
| Pfizer | 2 | $26 |
| Ferring Pharmaceuticals Inc. | 2 | $26 |
| W. L. Gore & Associates, Inc. | 1 | $22 |
| Portola Pharmaceuticals, LLC | 1 | $22 |
| Amgen | 1 | $22 |
| Phadia US Inc. | 1 | $14 |
| QOL Medical, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reltone 200 Mg$140
- Reltone 400 Mg$140
- STELARA$124
How this compares
$4,767 in reported general payments places this provider in the 55th percentile of 473 gastroenterology providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Famotidine | 17 | $211 |
| Pantoprazole Sodium | 11 | $147 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Chesapeake
- Felix TiongcoChesapeake$25K
- Walid MakdisiChesapeake$15K
- Jeremy DomanskiChesapeake$14K
- Rene RiveraChesapeake$13K
- Larry ClarkLynchburg$1.2M
- Arun SanyalRichmond$855K
- Mitchell ShiffmanNewport News$635K
- Bryan SauerCharlottesville$540K
- Michael RyanNorfolk$335K
- Brian WentworthCharlottesville$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.